Progenitor cell mobilisation enhances bony healing via improved neovascularisation and osteogenesis

X.X. Wang,R.J. Allen,J.P. Tutela,A. Sailon,Z. Schwam,P.B. Saadeh,S.M. Warren,J.G. McCarthy
DOI: https://doi.org/10.1016/j.ijom.2009.03.582
2009-01-01
Abstract:Background and Objectives: Delayed bony union or non-union is a great challenge in clinic. One explanation for this may be an inadequate revascularisation at local site. Recent studies have demonstrated that transplanted CD34+ cells, which possess the ability to differentiate into both endothelial cells and osteoblasts, assist in fracture healing. So, we hypothesise that AMD3100, a partial CXCR4 agonist and potent mobilising agent of bone marrow endothelial progenitor cells (EPC) may accelerate bony healing by improving neovascularisation and osteogenesis at the bony defect site.
What problem does this paper attempt to address?